Journal of Medical Microbiology · 1992 · 18 citations · 10 references
Veterinary MedicineInfectious DiseasesPathologyDiagnostic ParasitologyImmunology Of Infectious DiseasesImmunopathologyAntigen Detection AssaysHelminth DiagnosticsImmunopathology Of Parasitic DiseaseParasite AntigensParasitic Disease DiagnosisSerological DiagnosticsAntibodiesDiagnostic AntigensHelminth ImmunodiagnosisHydatid Disease DetectionImmunodiagnostic AssaysImmunodiagnostic BiomarkersParasitic Antigen DetectionSerological Diagnosis Of Parasitic Infections
Micro-enzyme-linked immunosorbent assay (Micro-ELISA) systems were developed and evaluated for the detection of circulating (free or immune-complexed) hydatid antigens in the sera of patients with hydatidosis, by employing monospecific antibodies to hydatid-specific antigens of 8-kDa and 116-kDa. Fifteen (75%) of 20 sera from patients with hydatidosis had both 8-kDa and 116-kDa antigens freely circulating in their sera while three and two samples, respectively, had only 8-kDa or 116-kDa antigen. All the surgically confirmed cases of hydatidosis had detectable levels of both 8-kDa and 116-kDa circulating immune complexes in glycine HCl-treated sera. However, none of the sera from control subjects (patients with cysticercosis, ascariasis, ancylostomiasis, hymenolepiasis, amoebic liver abscess or viral hepatitis) had any detectable level of either type of circulating specific antigen. These results suggest that the demonstration of either 8- or 116-kDa antigen(s) in free or immune-complex form could confirm the diagnosis of hydatidosis.
10
The biology of Echinococcus and hydatid disease
G. Nelson · Parasitology Today · 1986 · 279 citations
Albendazole in hydatid disease.
David L. Morris, P W Dykes, Brian Dickson et al. · BMJ · 1983 · 154 citations · Full text
Medicine, Cancer Biology, Oncology +17
Albendazole—Objective Evidence of Response in Human Hydatid Disease
David L. Morris · JAMA · 1985 · 153 citations